Atsutoshi Ota

417 total citations
20 papers, 348 citations indexed

About

Atsutoshi Ota is a scholar working on Molecular Biology, Organic Chemistry and Pharmaceutical Science. According to data from OpenAlex, Atsutoshi Ota has authored 20 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Organic Chemistry and 4 papers in Pharmaceutical Science. Recurrent topics in Atsutoshi Ota's work include Phenothiazines and Benzothiazines Synthesis and Activities (6 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Synthesis and biological activity (4 papers). Atsutoshi Ota is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (6 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Synthesis and biological activity (4 papers). Atsutoshi Ota collaborates with scholars based in Japan and United Kingdom. Atsutoshi Ota's co-authors include Yoichi Kawashima, Kouichi Kawazu, Kōji Yamamoto, Kazuhito Yamada, Minoru Nakamura, Susumu Ito, Susumu Ito, Toshimi Ikuse, Hidetoshi Tanioka and Toshimasa Ishida and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and Pharmaceutical Research.

In The Last Decade

Atsutoshi Ota

19 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atsutoshi Ota Japan 9 136 102 96 93 66 20 348
Whei‐Mei Wu United States 13 148 1.1× 70 0.7× 41 0.4× 86 0.9× 25 0.4× 20 398
James W. Sieg United States 8 111 0.8× 256 2.5× 30 0.3× 180 1.9× 30 0.5× 9 419
Pratik Saha United States 6 80 0.6× 121 1.2× 11 0.1× 57 0.6× 45 0.7× 7 278
George Lew United States 12 124 0.9× 12 0.1× 119 1.2× 44 0.5× 28 0.4× 19 329
Irving Weliky United States 12 87 0.6× 23 0.2× 32 0.3× 19 0.2× 11 0.2× 21 361
Louis‐David Cantin Canada 12 145 1.1× 17 0.2× 190 2.0× 14 0.2× 11 0.2× 14 393
Caroline Leriche France 10 154 1.1× 145 1.4× 206 2.1× 31 0.3× 15 0.2× 11 387
Carlos Lázaro‐Milla Spain 14 34 0.3× 87 0.9× 405 4.2× 8 0.1× 94 1.4× 30 562
Larry Gifford United Kingdom 8 63 0.5× 56 0.5× 22 0.2× 16 0.2× 22 0.3× 13 290
Michael G. Bell United States 7 156 1.1× 81 0.8× 46 0.5× 11 0.1× 10 0.2× 10 398

Countries citing papers authored by Atsutoshi Ota

Since Specialization
Citations

This map shows the geographic impact of Atsutoshi Ota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsutoshi Ota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsutoshi Ota more than expected).

Fields of papers citing papers by Atsutoshi Ota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsutoshi Ota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsutoshi Ota. The network helps show where Atsutoshi Ota may publish in the future.

Co-authorship network of co-authors of Atsutoshi Ota

This figure shows the co-authorship network connecting the top 25 collaborators of Atsutoshi Ota. A scholar is included among the top collaborators of Atsutoshi Ota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsutoshi Ota. Atsutoshi Ota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ota, Atsutoshi, et al.. (2002). Cyclosporine A Formulation Affects Its Ocular Distribution in Rabbits. Pharmaceutical Research. 19(1). 108–111. 58 indexed citations
2.
Ota, Atsutoshi, et al.. (2001). Platelet Activating Factor Degradation in Tear Fluid from Guinea Pigs with Allergic Conjunctivitis. Journal of Ocular Pharmacology and Therapeutics. 17(1). 83–91. 6 indexed citations
3.
Kawazu, Kouichi, et al.. (1999). Characterization of the Carrier-mediated Transport of Levofloxacin, a Fluoroquinolone Antimicrobial Agent, in Rabbit Cornea. Journal of Pharmacy and Pharmacology. 51(7). 797–801. 31 indexed citations
4.
Yamada, Kazuhito, et al.. (1999). Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin.. PubMed. 40(8). 1738–44. 58 indexed citations
5.
Kawazu, Kouichi, et al.. (1999). Cultured Rabbit Corneal Epithelium Elicits Levofloxacin Absorption and Secretion. Journal of Pharmacy and Pharmacology. 51(7). 791–796. 14 indexed citations
6.
Kawazu, Kouichi, et al.. (1998). Beta adrenergic antagonist permeation across cultured rabbit corneal epithelial cells grown on permeable supports. Current Eye Research. 17(2). 125–131. 41 indexed citations
7.
Ota, Atsutoshi, et al.. (1996). Quantitative Structure-Activity Relationships of Ca2+-Antagonistic Semotiadil Congeners.. Chemical and Pharmaceutical Bulletin. 44(3). 542–546. 5 indexed citations
8.
Ota, Atsutoshi, et al.. (1993). Synthesis of Thiazolidine-2-thione Derivatives and Evaluation of Their Hepatoprotective Effects.. Chemical and Pharmaceutical Bulletin. 41(5). 876–881. 12 indexed citations
9.
Ota, Atsutoshi, Yoichi Kawashima, Hirofumi Ohishi, & Toshimasa Ishida. (1993). Conformational Studies of Semotiadil (SD-3211), a Novel Ca2+ Antagonist.. Chemical and Pharmaceutical Bulletin. 41(10). 1681–1685. 6 indexed citations
10.
Ota, Atsutoshi, et al.. (1992). Molecular Mechanics Study on the Folded Conformation of Semotiadil, a Ca2+ Antagonist Having a Benzothiazine Skeleton.. Chemical and Pharmaceutical Bulletin. 40(11). 2901–2904. 2 indexed citations
11.
Ito, Susumu, Atsutoshi Ota, Kōji Yamamoto, & Yoichi Kawashima. (1992). Resolution of the enantiomers of thiol compounds by reversed-phase liquid chromatography using chiral derivatization with 2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl isothiocyanate. Journal of Chromatography A. 626(2). 187–196. 33 indexed citations
12.
Ota, Atsutoshi, Susumu Ito, & Yoichi Kawashima. (1992). Direct high-performance liquid chromatographic resolution of a novel benzothiazine Ca2+ antagonist and related compounds. Journal of Chromatography A. 593(1-2). 37–40. 2 indexed citations
14.
Ito, Susumu, et al.. (1990). Synthesis and calcium ion antagonistic activity of 2-[2-[(aminoalkyl)oxy]-5-methoxyphenyl]-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzothiazines. Journal of Medicinal Chemistry. 33(7). 1898–1905. 55 indexed citations
15.
Ota, Atsutoshi, et al.. (1988). A Novel, Convenient Synthesis of 2-Aryl-3-oxo-3,4-dihydro-2H-1,4-benzothiazines. Synthesis. 1988(8). 599–604. 10 indexed citations
16.
Kurihara, Takushi, Atsutoshi Ota, Hidehito Urata, et al.. (1984). Synthesis of Dinucleotide-like Compounds Containing a 5'-Deoxy-5'-adenosineacetic Acid. Heterocycles. 21(2). 790–790.
17.
Kurihara, Takushi, et al.. (1984). Synthesis and physical properties of N‐2‐phenylethyl‐ and N‐2‐(3‐indolyl)ethyl‐5′‐deoxy‐5′‐adenosineacetamides. Journal of Heterocyclic Chemistry. 21(1). 259–260. 1 indexed citations
18.
Kurihara, Takushi, et al.. (1983). Improved Synthesis of 5'-Deoxy-5'-adenosineacetic Acid. Chemical and Pharmaceutical Bulletin. 31(6). 2126–2129. 3 indexed citations
19.
Ishida, Toshimasa, et al.. (1983). Crystallographic and1H nuclear magnetic resonance studies of 5′-deoxy-5′-adenosineacetic acid; a model nucleotide of adenosine-5′-monophosphate. Journal of the Chemical Society Perkin Transactions 1. 1325–1331. 3 indexed citations
20.
Ishida, Toshimasa, Masatoshi Inoue, Atsutoshi Ota, & Takushi Kurihara. (1980). X-Ray crystal structure of 5′-deoxy-5′-adenosineacetic acid; a model nucleotide of adenosine-5′-monophosphate. Journal of the Chemical Society Chemical Communications. 1074–1075. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026